Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.59 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.55 |
| ▸ | FAAH | O00519 | 2/20 | 0.53 |
| ▸ | RAD52 | P43351 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | ACHE | P22303 | 6/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL394098 | 0.98 | NAAA (0.62) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL27285973 | 0.98 | NAAA (0.62) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL168311 | 0.98 | NAAA (0.61) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL4883420 | 0.96 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL7519633 | 0.96 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL8377208 | 0.96 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL81047 | 0.96 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL5267200 | 0.96 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| SCHEMBL8379909 | 0.96 | NAAA (0.64) | NAAAEPHX1FAAHRAD52NPSR1 | |
| Hydrochloric Acid SCHEMBL5267197 | 0.94 | NAAA (0.62) | NAAAEPHX1FAAHRAD52NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024135446-A1 | SOLID HAIR TREATMENT | 資生堂ホネケーキ工業株式会社 | 2024-06-27 | — | — | WO | disclosed |
| WO-2024135300-A1 | COSMETIC COMPOSITION, COSMETIC COMPOSITION FOR SUPPRESSING DISCOLORATION, AND DISCOLORATION SUPPRESSANT | 株式会社資生堂 | 2024-06-27 | — | — | WO | disclosed |
| EP-4356897-A1 | POWDER COSMETIC AND PRODUCTION METHOD FOR SAME | Shiseido Company, Ltd. (JP) | 2024-04-24 | — | — | EP | disclosed |
| WO-2024075548-A1 | GEL COMPOSITION AND OIL-IN-WATER-TYPE COMPOSITION | 株式会社 資生堂 | 2024-04-11 | — | — | WO | disclosed |
| WO-2024075678-A1 | METHOD FOR PRODUCING BIO-DERIVED BRANCHED ALKYL GLYCERYL ETHER, AND BIO-DERIVED BRANCHED ALKYL GLYCERYL ETHER PRODUCED BY SAID METHOD | 株式会社ADEKA | 2024-04-11 | — | — | WO | disclosed |
| WO-2024071313-A1 | COSMETIC COMPOSITION AND COSMETIC | 株式会社日本触媒 | 2024-04-04 | — | — | WO | disclosed |
| US-20230044107-A1 | WATER IN OIL TYPE EMULSION COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2023-02-09 | — | — | US | disclosed |
| EP-3369418-B1 | COMPOSITION FOR CORRECTING PORES OF THE SKIN | SHISEIDO CO LTD (JP) | 2021-06-23 | — | — | EP | disclosed |
| US-20210137801-A1 | METHOD OF PREPARING A COSMETIC COMPOSITION | SHISEIDO COMPANY, LTD. (JP) | 2021-05-13 | — | — | US | disclosed |
| EP-3225643-B1 | POLYURETHANE POLYUREA, METHOD FOR PRODUCING SAME AND COSMETIC COMPOSITION CONTAINING SAME | ADEKA CORP (JP) | 2020-12-30 | — | — | EP | disclosed |
| US-8232321-B2 | Alkylene oxide derivative and skin external preparation containing the same | SHISEIDO COMPANY, LTD. (JP) | 2012-07-31 | — | — | US | disclosed |
| EP-2474302-A1 | SUNSCREEN COSMETIC COMPOSITION CONTAINING ULTRAVIOLET ABSORBER | Adeka Corporation (JP) | 2012-07-11 | — | — | EP | disclosed |
| US-20100190864-A1 | Alkylene Oxide Derivative And Skin External Preparation Containing The Same | SHISEIDO COMPANY LTD. (JP) | 2010-07-29 | — | — | US | disclosed |
| EP-2174972-A1 | ALKYLENE OXIDE DERIVATIVE AND SKIN EXTERNAL PREPARATION CONTAINING THE SAME | Shiseido Company, Ltd. (JP) | 2010-04-14 | — | — | EP | disclosed |
| US-20100075882-A1 | External Skin Preparation And Skin Cleanser | SHISEIDO COMPANY LTD. (JP) | 2010-03-25 | — | — | US | disclosed |
| US-20090197948-A1 | Skin External Preparation | SHISEIDO CO., LTD. (JP) | 2009-08-06 | — | — | US | disclosed |
| EP-2082729-A1 | EXTERNAL PREPARATION FOR SKIN AND CLEANSING AGENT FOR SKIN | SHISEIDO COMPANY, LTD. (JP) | 2009-07-29 | — | — | EP | disclosed |
| EP-2027849-A1 | EXTERNAL PREPARATION FOR SKIN | Shiseido Company, Limited (JP) | 2009-02-25 | — | — | EP | disclosed |
| US-20080064723-A1 | Aminocyclohexane carboxylic acid and its esters, aminocyclohexane derivatives such as aminocyclohexanol, and piperidinecarboxylic acid and its esters, hydroxypiperidine ; applied to human scalp | SHISEIDO COMPANY, LTD. (JP) | 2008-03-13 | — | — | US | disclosed |
| EP-1806121-A1 | ANTI-GRAYING PREPARATION | Shiseido Company, Limited (JP) | 2007-07-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197948-A1 | Skin External Preparation | CUTA, OXER1, AKR1B10 | NAAA 2810/4885EPHX1 368/4885FAAH 548/4885 |
| US-20100190864-A1 | Alkylene Oxide Derivative And Skin External Preparation Containing The Same | CUTA, OXER1, OR51E2 | NAAA 3730/4885EPHX1 1453/4885FAAH 768/4885 |
| US-20080064723-A1 | Aminocyclohexane carboxylic acid and its esters, aminocyclohexane derivatives such as aminocyclohexanol, and piperidinecarboxylic acid and its esters, hydroxypiperidine ; applied to human scalp | HCAR1, HCAR3, DDC | NAAA 411/4885EPHX1 2639/4885FAAH 380/4885 |
| US-20100075882-A1 | External Skin Preparation And Skin Cleanser | CUTA, AOC2, AKR1B10 | NAAA 3591/4885EPHX1 738/4885FAAH 174/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.